| mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
| mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
| mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.0073 |
0.9 |
| mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.9 |
| mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.9 |
| mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.9 |
| mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.9 |
| mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.9 |